Literature DB >> 20824907

Lenalidomide efficacy in bortezomib-resistant myeloma.

Alessandro Gozzetti, Rosaria Crupi, Marzia Defina, Monica Bocchia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20824907     DOI： 10.1038/nrclinonc.2010.31-c2

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  Renal recovery with lenalidomide in a patient with bortezomib-resistant multiple myeloma.

Authors:  Heinz Ludwig; Niklas Zojer
Journal:  Nat Rev Clin Oncol       Date:  2010-03-30       Impact factor: 66.675

2.  Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13.

Authors:  Donna Reece; Kevin W Song; Tommy Fu; Birgitte Roland; Hong Chang; Douglas E Horsman; Adnan Mansoor; Christine Chen; Esther Masih-Khan; Young Trieu; Helene Bruyere; Douglas A Stewart; Nizar J Bahlis
Journal:  Blood       Date:  2009-03-30       Impact factor: 22.113
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.